SCHEMBL24538043

SCHEMBL24538043

C[Si](C)(C)CCOCOc1ccccc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.47
KDM4E B2RXH2 4/20 0.43
LMNA P02545 4/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
HPGD P15428 1/20 0.40
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
GRM4 Q14833 1/20 0.39
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34475296 1.00 HTR7 (0.47) HTR7KDM4ELMNAHTTMAPT
SCHEMBL27321675 0.90 MAPT (0.50) HTR7KDM4ELMNAHTTMAPT
SCHEMBL29556152 0.86 LMNA (0.35) HTR7KDM4ELMNAHTTMAPT
SCHEMBL2131582 0.83 KDM4E (0.33) HTR7KDM4ELMNAHTTMAPT
SCHEMBL24537868 0.81 ALOX5AP (0.42) HTR7KDM4ELMNAHTT
SCHEMBL29744608 0.81 ALOX5AP (0.42) HTR7KDM4ELMNAHTT
SCHEMBL31437246 0.81 S1PR4 (0.44) KDM4ELMNAHTTMAPTCYP1A2
SCHEMBL8710247 0.81 S1PR4 (0.44) KDM4ELMNAHTTMAPTCYP1A2
SCHEMBL22588118 0.80 ALDH1A1 (0.50) KDM4ELMNAMAPTCYP1A2CYP2C9
SCHEMBL10112340 0.80 ALOX5AP (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES INC (US) 2023-08-31 US disclosed
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES INC (US) 2023-08-31 US disclosed
WO-2022133083-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271954-A1 COMPOUNDS USEFUL AS T CELL ACTIVATORS DGKZ, DGKA, DGKG HTR7 4051/4885KDM4E 3666/4885LMNA 1800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.